MA
MYDA Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.19M | Buy |
370,000
+80,000
| +28% | +$1.12M | 0.91% | 21 |
|
|
2025
Q1 | $4.54M | Buy |
290,000
+90,000
| +45% | +$1.41M | 0.79% | 20 |
|
|
2024
Q4 | $2.79M | Buy |
200,000
+80,000
| +67% | +$1.11M | 0.7% | 35 |
|
|
2024
Q3 | $1.12M | Buy |
120,000
+45,000
| +60% | +$419K | 0.24% | 60 |
|
|
2024
Q2 | $698K | Hold |
75,000
| – | – | 0.15% | 66 |
|
|
2024
Q1 | $743K | Sell |
75,000
-145,000
| -66% | -$1.44M | 0.21% | 67 |
|
|
2023
Q4 | $711K | Buy |
+220,000
| New | +$711K | 0.24% | 48 |
|